PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.63%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-0.43%
Negative gross profit growth while MRVL is at 12.24%. Joel Greenblatt would examine cost competitiveness or demand decline.
-2.53%
Negative EBIT growth while MRVL is at 60.15%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-0.40%
Negative operating income growth while MRVL is at 60.15%. Joel Greenblatt would press for urgent turnaround measures.
9.72%
Net income growth under 50% of MRVL's 81.42%. Michael Burry would suspect the firm is falling well behind a key competitor.
10.53%
EPS growth under 50% of MRVL's 81.63%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
10.71%
Diluted EPS growth under 50% of MRVL's 81.63%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.21%
Share reduction while MRVL is at 0.17%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.53%
Reduced diluted shares while MRVL is at 0.17%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.21%
Maintaining or increasing dividends while MRVL cut them. John Neff might see a strong edge in shareholder returns.
-51.48%
Negative OCF growth while MRVL is at 55.49%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-56.63%
Negative FCF growth while MRVL is at 87.54%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
37.56%
10Y revenue/share CAGR above 1.5x MRVL's 19.28%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
18.56%
Positive 5Y CAGR while MRVL is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
4.90%
Positive 3Y CAGR while MRVL is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
58.74%
10Y OCF/share CAGR above 1.5x MRVL's 7.71%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
56.76%
Positive OCF/share growth while MRVL is negative. John Neff might see a comparative advantage in operational cash viability.
14.75%
3Y OCF/share CAGR under 50% of MRVL's 121.00%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
136.30%
Net income/share CAGR above 1.5x MRVL's 59.19% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
100.76%
Positive 5Y CAGR while MRVL is negative. John Neff might view this as a strong mid-term relative advantage.
26.23%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
4.46%
Below 50% of MRVL's 81.23%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-16.33%
Negative 5Y equity/share growth while MRVL is at 16.20%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-22.07%
Negative 3Y equity/share growth while MRVL is at 36.16%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
647.52%
Dividend/share CAGR of 647.52% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
165.01%
5Y dividend/share CAGR above 1.5x MRVL's 0.27%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
80.30%
3Y dividend/share CAGR above 1.5x MRVL's 0.04%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
22.53%
Our AR growth while MRVL is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
0.10%
We show growth while MRVL is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-4.08%
Negative asset growth while MRVL invests at 0.31%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-12.98%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
6.76%
We have some new debt while MRVL reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-2.33%
Our R&D shrinks while MRVL invests at 4.20%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.21%
SG&A declining or stable vs. MRVL's 3.61%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.